Advertisement
Advertisement

BCTX

BCTX logo

Briacell Therapeutics Corp. Common Shares

5.07
USD
-0.61
-12.03%
Feb 21, 16:00 UTC -5
Closed
exchange

After-Market

4.46

-0.61
-12.03%

Briacell Therapeutics Corp. Common Shares Profile

About

BriaCell Therapeutics Corp. is an immuno-oncology focused biotechnology company. It developed a patented whole-cell vaccine, cancer immunotherapy technology called the `BriaVax` vaccine for cancer. The company's technology consists of Bria-IMT(TM), Bria-OTS(TM) and BriaDx(TM) which are in clinical stage. BriaCell Therapeutics Corp. is headquartered in West Vancouver, Canada.

Info & Links

CEO

William V. Williams

Headquarters

235 15th Street, Suite 300
WEST VANCOUVER, A1 V7T 2X1, CANADA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.briacell.com

Auditor

MNP LLP

Share holders

--

Employees

18

Briacell Therapeutics Corp. Common Shares Statistics

Valuation Measures

Market Capitalization2

13.15M

Enterprise Value

7.36M

Enterprise Value/EBITDA(ttm)

-0.25

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

3.30

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

-1.37%

Return on Assets(ttm)

-191.19%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-29.87M

Net Income Available to Common(ttm)

-16.60M

Diluted EPS(ttm)

-13.34

Share Statistics

Beta (5Y Monthly)

1.59

52-Week Change

-90.53%

S&P 500 52-Week Change

18.16%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

2.95M

Dividend Yield

0.00%

Float4

3.50M

% Held by Insiders

5.73%

% Held by Institutions

15.42%

Balance Sheet

Total Cash(mrq)

5.79M

Total Cash Per Share(mrq)

1.96

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.65%

Quick Ratio(mrq)

1.65%

Book Value Per Share(mrq)

1.54

Cash Flow

Operating Cash Flow Per Share(ytd)

-3.91

Free Cash Flow(ytd)

-6.96M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement